RPS27L

gene
On this page

Summary

RPS27L (ribosomal protein S27 like, HGNC:18476) is a protein-coding gene on chromosome 15q22.2, encoding Ribosomal protein eS27-like (Q71UM5).

This gene encodes a protein sharing 96% amino acid similarity with ribosomal protein S27, which suggests the encoded protein may be a component of the 40S ribosomal subunit.

Source: NCBI Gene 51065 — RefSeq curated summary.

At a glance

  • GWAS associations: 2
  • Clinical variants (ClinVar): 7 total
  • Druggable target: yes
  • MANE Select transcript: NM_015920

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:18476
Approved symbolRPS27L
Nameribosomal protein S27 like
Location15q22.2
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000185088
Ensembl biotypeprotein_coding
OMIM612055
Entrez51065

Gene structure

Transcript identifiers

Ensembl transcripts: 10 — 8 protein_coding, 1 retained_intron, 1 protein_coding_CDS_not_defined

ENST00000330964, ENST00000411926, ENST00000439025, ENST00000455271, ENST00000462430, ENST00000482846, ENST00000559763, ENST00000635699, ENST00000879550, ENST00000935562

RefSeq mRNA: 1 — MANE Select: NM_015920 NM_015920

CCDS: CCDS42048

Canonical transcript exons

ENST00000330964 — 4 exons

ExonStartEnd
ENSE000013129826314824963154060
ENSE000015365316315740063157477
ENSE000016973276315562163155731
ENSE000036886976315641363156521

Expression profiles

Bgee: expression breadth ubiquitous, 288 present calls, max score 99.64.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 332.2366 / max 4580.5657, expressed in 1825 samples.

FANTOM5 promoters (4 alternative TSS)

Promoter IDTPM avgSamples expressed
150409330.99361825
1504110.6172362
1504080.4215202
1504100.204271

Top tissues by expression

288 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
seminal vesicleUBERON:000099899.64gold quality
choroid plexus epitheliumUBERON:000391199.63gold quality
jejunal mucosaUBERON:000039999.48gold quality
palpebral conjunctivaUBERON:000181299.41gold quality
parotid glandUBERON:000183199.41gold quality
nephron tubuleUBERON:000123199.38gold quality
mucosa of sigmoid colonUBERON:000499399.35gold quality
right adrenal gland cortexUBERON:003582799.24gold quality
colonic mucosaUBERON:000031799.23gold quality
body of pancreasUBERON:000115099.22gold quality
cauda epididymisUBERON:000436099.20gold quality
right adrenal glandUBERON:000123399.17gold quality
renal medullaUBERON:000036299.16gold quality
adrenal cortexUBERON:000123599.14gold quality
visceral pleuraUBERON:000240199.10gold quality
caput epididymisUBERON:000435899.10gold quality
cardia of stomachUBERON:000116299.09gold quality
pylorusUBERON:000116699.09gold quality
left adrenal glandUBERON:000123499.09gold quality
oocyteCL:000002399.08gold quality
left adrenal gland cortexUBERON:003582599.08gold quality
calcaneal tendonUBERON:000370199.06gold quality
superficial temporal arteryUBERON:000161499.05gold quality
duodenumUBERON:000211499.05gold quality
thoracic aortaUBERON:000151599.03gold quality
descending thoracic aortaUBERON:000234599.03gold quality
ascending aortaUBERON:000149699.02gold quality
corpus epididymisUBERON:000435998.98gold quality
pleuraUBERON:000097798.97gold quality
mammary ductUBERON:000176598.96gold quality

Single-cell (SCXA)

Detected in 14 experiment(s), a significant marker in 5.

ExperimentMarker?Max mean expression
E-HCAD-1yes44.52
E-HCAD-5yes39.11
E-CURD-46yes19.29
E-MTAB-8142yes13.27
E-MTAB-8495no2039.15
E-MTAB-8205no1750.56
E-MTAB-9689no1510.27
E-MTAB-7381no671.29
E-HCAD-6no542.31
E-HCAD-56no432.91
E-GEOD-93593no12.97
E-MTAB-6678no7.76
E-MTAB-8410no3.46
E-ANND-3no0.00

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): TP53

miRNA regulators (miRDB)

53 targeting RPS27L, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-7110-3P100.0073.182486
HSA-MIR-5011-5P100.0083.465820
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-190A-3P100.0080.355520
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-373-5P99.9875.364753
HSA-MIR-616-5P99.9875.584775
HSA-MIR-1468-3P99.9672.743797
HSA-MIR-548AA99.9670.643753
HSA-MIR-548AP-3P99.9670.643753
HSA-MIR-548T-3P99.9670.643753
HSA-MIR-368699.9070.532432
HSA-MIR-6780A-5P99.8866.692776
HSA-MIR-612499.8769.783551
HSA-MIR-548AR-3P99.8571.263889
HSA-MIR-4728-5P99.8569.394718
HSA-MIR-132399.8369.892471
HSA-MIR-548AZ-3P99.8270.563549
HSA-MIR-548BC99.8270.613524
HSA-MIR-548E-3P99.8270.593514
HSA-MIR-548F-3P99.8270.593540
HSA-MIR-323A-3P99.7970.301739
HSA-MIR-1273H-5P99.7766.322471
HSA-MIR-548A-3P99.7670.583524
HSA-MIR-548O-3P99.7469.302228
HSA-MIR-471999.7372.103329
HSA-MIR-4524A-3P99.7266.852406
HSA-MIR-1212999.7267.451311
HSA-MIR-30B-3P99.7065.762325
HSA-MIR-3689A-3P99.7065.732306

Literature-anchored findings (GeneRIF, showing 4)

  • Elevated RPS27L may improve the prognoses of certain colorectal cancer patients by enhancing the DNA repair capacity of their colonic cells. (PMID:23826192)
  • The study suggests that RPS27L reduction might play a promoting role during breast tumorigenesis by autophagy induction via the beta-TrCP-DEPTOR-mTORC1 axis. (PMID:30425236)
  • Neddylation modification of ribosomal protein RPS27L or RPS27 by MDM2 or NEDP1 regulates cancer cell survival. (PMID:32779270)
  • Inactivation of ribosomal protein S27-like impairs DNA interstrand cross-link repair by destabilization of FANCD2 and FANCI. (PMID:33051438)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriorps27lENSDARG00000100513
mus_musculusRps27lENSMUSG00000036781
rattus_norvegicusRps27lENSRNOG00000050473

Paralogs (1): RPS27 (ENSG00000177954)

Protein

Protein identifiers

Ribosomal protein eS27-likeQ71UM5 (reviewed: Q71UM5)

Alternative names: 40S ribosomal protein S27-like, Small ribosomal subunit protein eS27-like

All UniProt accessions (4): Q71UM5, C9J1C5, C9JLI6, H0YMV8

UniProt curated annotations — full annotation on UniProt →

Cofactor. Binds 1 zinc ion per subunit.

Similarity. Belongs to the eukaryotic ribosomal protein eS27 family.

RefSeq proteins (1): NP_057004* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000592Ribosomal_eS27Family
IPR011332Ribosomal_zn-bdHomologous_superfamily
IPR023407Ribosomal_eS27_Zn-bd_dom_sfHomologous_superfamily

Pfam: PF01667

UniProt features (5 total): chain 1, zinc finger region 1, region of interest 1, compositionally biased region 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q71UM5-F192.930.89

Function

Pathways and Gene Ontology

Reactome pathways

50 pathways

IDPathway
R-HSA-156827L13a-mediated translational silencing of Ceruloplasmin expression
R-HSA-156902Peptide chain elongation
R-HSA-1799339SRP-dependent cotranslational protein targeting to membrane
R-HSA-192823Viral mRNA Translation
R-HSA-2408557Selenocysteine synthesis
R-HSA-6791226Major pathway of rRNA processing in the nucleolus and cytosol
R-HSA-72649Translation initiation complex formation
R-HSA-72689Formation of a pool of free 40S subunits
R-HSA-72695Formation of the ternary complex, and subsequently, the 43S complex
R-HSA-72702Ribosomal scanning and start codon recognition
R-HSA-72706GTP hydrolysis and joining of the 60S ribosomal subunit
R-HSA-72764Eukaryotic Translation Termination
R-HSA-9010553Regulation of expression of SLITs and ROBOs
R-HSA-9633012Response of EIF2AK4 (GCN2) to amino acid deficiency
R-HSA-9735869SARS-CoV-1 modulates host translation machinery
R-HSA-9754678SARS-CoV-2 modulates host translation machinery
R-HSA-975956Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
R-HSA-975957Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
R-HSA-9954714PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA
R-HSA-9954716ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA
R-HSA-1266738Developmental Biology
R-HSA-1430728Metabolism
R-HSA-156842Eukaryotic Translation Elongation
R-HSA-1643685Disease
R-HSA-168255Influenza Infection
R-HSA-168273Influenza Viral RNA Transcription and Replication
R-HSA-2262752Cellular responses to stress
R-HSA-2408522Selenoamino acid metabolism
R-HSA-376176Signaling by ROBO receptors
R-HSA-392499Metabolism of proteins

MSigDB gene sets: 273 (showing top): GOBP_RIBOSOME_BIOGENESIS, GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE_BY_P53_CLASS_MEDIATOR, MODULE_151, SHEPARD_CRASH_AND_BURN_MUTANT_UP, GOBP_CELL_CYCLE_PHASE_TRANSITION, JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP, GOBP_RIBOSOME_ASSEMBLY, CHANDRAN_METASTASIS_DN, GOBP_TRANSLATION, GOBP_POST_TRANSCRIPTIONAL_REGULATION_OF_GENE_EXPRESSION, CAIRO_HEPATOBLASTOMA_CLASSES_DN, GOMF_TRANSLATION_REGULATOR_ACTIVITY, GOBP_NEGATIVE_REGULATION_OF_CELL_CYCLE_PROCESS, GOBP_APOPTOTIC_SIGNALING_PATHWAY, GOBP_NEGATIVE_REGULATION_OF_CELL_CYCLE

GO Biological Process (6): ribosomal small subunit assembly (GO:0000028), translation (GO:0006412), DNA damage response, signal transduction by p53 class mediator (GO:0030330), mitotic G1 DNA damage checkpoint signaling (GO:0031571), intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771), positive regulation of translation (GO:0045727)

GO Molecular Function (6): RNA binding (GO:0003723), structural constituent of ribosome (GO:0003735), zinc ion binding (GO:0008270), translation activator activity (GO:0008494), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (4): nucleus (GO:0005634), cytosolic small ribosomal subunit (GO:0022627), ribosome (GO:0005840), ribonucleoprotein complex (GO:1990904)

Reactome top-level categories

Rollup of top-14 pathways:

CategoryPathways
Cap-dependent Translation Initiation4
Translation2
Nonsense-Mediated Decay (NMD)2
Ribosome-associated quality control2
Eukaryotic Translation Initiation1
Eukaryotic Translation Elongation1
Influenza Viral RNA Transcription and Replication1
Selenoamino acid metabolism1
rRNA processing in the nucleus and cytosol1
Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S1
Signaling by ROBO receptors1
Cellular response to starvation1
SARS-CoV-1-host interactions1
SARS-CoV-2-host interactions1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
protein-RNA complex assembly1
ribosome assembly1
ribosomal small subunit biogenesis1
peptidyltransferase activity1
translational initiation1
translational elongation1
translational termination1
macromolecule biosynthetic process1
protein metabolic process1
protein biosynthetic process1
signal transduction in response to DNA damage1
signal transduction by p53 class mediator1
mitotic G1 phase1
mitotic DNA damage checkpoint signaling1
mitotic G1/S transition checkpoint signaling1
intrinsic apoptotic signaling pathway in response to DNA damage1
intrinsic apoptotic signaling pathway by p53 class mediator1
translation1
regulation of translation1
positive regulation of gene expression1
positive regulation of protein metabolic process1
nucleic acid binding1
structural molecule activity1
ribosome1
transition metal ion binding1
translation regulator activity1
positive regulation of translation1
binding1
cation binding1
intracellular membrane-bounded organelle1
small ribosomal subunit1
cytosolic ribosome1
intracellular membraneless organelle1
protein-containing complex1

Protein interactions and networks

STRING

2651 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
RPS27LRPL11P25121710
RPS27LRPL15P39030676
RPS27LRPL21P46778674
RPS27LRPL38P23411671
RPS27LRPL22P35268655
RPS27LRPS14P06366637
RPS27LRPL7P18124637
RPS27LRPL8P25120622
RPS27LRPL22L1Q6P5R6617
RPS27LRPL26P61254615
RPS27LRPL5P46777609
RPS27LRPL9P32969605
RPS27LRPS19P39019580
RPS27LTP53P04637575
RPS27LRPS25P25111569

IntAct

115 interactions, top by confidence:

ABTypeScore
RPS27LMDM2psi-mi:“MI:0407”(direct interaction)0.620
MDM2RPS27Lpsi-mi:“MI:0915”(physical association)0.620
RPS27LMDM2psi-mi:“MI:0915”(physical association)0.620
RPS27LMDM2psi-mi:“MI:0403”(colocalization)0.620
PPP2R2BDDX3Xpsi-mi:“MI:0914”(association)0.460
ESR2FBLL1psi-mi:“MI:0914”(association)0.460
TUBA1ATUBAL3psi-mi:“MI:0914”(association)0.420
RPS27LRPS7psi-mi:“MI:0915”(physical association)0.400
RPS27LE7psi-mi:“MI:0915”(physical association)0.370
ZMYND8MTA3psi-mi:“MI:0914”(association)0.350
Rrbp1PIPSLpsi-mi:“MI:0914”(association)0.350
Ktn1ESYT2psi-mi:“MI:0914”(association)0.350
NPM1RPSApsi-mi:“MI:0914”(association)0.350
JUNTPM3psi-mi:“MI:0914”(association)0.350
VWA8psi-mi:“MI:0914”(association)0.350
ESYT2psi-mi:“MI:0914”(association)0.350
E6PLOD2psi-mi:“MI:0914”(association)0.350
E7COPEpsi-mi:“MI:0914”(association)0.350
E5ESYT2psi-mi:“MI:0914”(association)0.350
PGRMC1psi-mi:“MI:0914”(association)0.350
HAX1psi-mi:“MI:0914”(association)0.350
BVLF1VWA8psi-mi:“MI:0914”(association)0.350

BioGRID (319): RPS27L (Affinity Capture-RNA), RPS27L (Co-fractionation), RPS27L (Affinity Capture-MS), RPS27L (Affinity Capture-MS), RPS27L (Affinity Capture-MS), RPS27L (Affinity Capture-MS), RPS27L (Affinity Capture-MS), RPS27L (Affinity Capture-MS), RPS27L (Affinity Capture-MS), RPS27L (Affinity Capture-MS), RPS27L (Affinity Capture-MS), RPS27L (Affinity Capture-MS), RPS27L (Affinity Capture-MS), RPS27L (Affinity Capture-MS), RPS27L (Affinity Capture-MS)

ESM2 similar proteins: A0A1D8PTI7, A0A1L8H579, A0A1W2PPG7, A1X8D9, G1TZ76, O64650, O74330, P03131, P06459, P09003, P0C567, P0DOC8, P11332, P17387, P24051, P35997, P36826, P36833, P38711, P40569, P42677, P47903, P47904, P55833, P68834, P68835, P68958, P68959, Q02271, Q13670, Q1X709, Q2KHT7, Q39072, Q3T0B7, Q5RBK1, Q5RGZ1, Q67616, Q67708, Q6DRC3, Q6ZWU9

Diamond homologs: A0A1D8PTI7, A1RRN0, A2BN94, A3MUV2, A4WLR8, B1YAF9, B6YT34, C5A6X9, G1TZ76, O64650, O74330, P24051, P35997, P38654, P38711, P42677, P47903, P47904, P55833, P58078, Q2KHT7, Q3T0B7, Q46C77, Q4J9B1, Q5JE50, Q5RBK1, Q6ZWU9, Q6ZWY3, Q71TY3, Q71UM5, Q7RVN2, Q8L953, Q8T1V4, Q8U474, Q8ZTY4, Q96564, Q973F9, Q97Z80, Q9M2F1, Q9TXP0

SIGNOR signaling

1 interactions.

AEffectBMechanism
RPS27L“form complex”“40S cytosolic small ribosomal subunit”binding

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 135 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Ribosomal scanning and start codon recognition1018.7×1e-08
Formation of the ternary complex, and subsequently, the 43S complex816.9×7e-07
Translation initiation complex formation916.8×1e-07
Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S616.0×5e-05
Eukaryotic Translation Initiation515.1×4e-04
Cap-dependent Translation Initiation515.1×4e-04
SARS-CoV-1 modulates host translation machinery515.1×4e-04
SRP-dependent cotranslational protein targeting to membrane1514.7×2e-11

GO biological processes:

GO termPartnersFoldFDR
stress granule assembly525.9×2e-04
translational initiation721.6×8e-06
cytoplasmic translation1320.8×4e-11
negative regulation of translation813.5×3e-05
translation1311.5×4e-08
ribosomal small subunit biogenesis59.8×1e-02
positive regulation of translation59.8×1e-02

Disease & clinical

Clinical variants and AI predictions

ClinVar

7 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance0
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1365 predictions. Top by Δscore:

VariantEffectΔscore
15:63126855:A:AGacceptor_gain1.0000
15:63126855:AAAG:Aacceptor_gain1.0000
15:63126856:A:Gacceptor_gain1.0000
15:63126857:A:AGacceptor_gain1.0000
15:63126858:G:Aacceptor_gain1.0000
15:63126858:G:GAacceptor_gain1.0000
15:63126858:GG:Gacceptor_loss1.0000
15:63126858:GGTTT:Gacceptor_gain1.0000
15:63127044:GAAAA:Gdonor_loss1.0000
15:63127046:AAAG:Adonor_loss1.0000
15:63127047:AAGG:Adonor_loss1.0000
15:63127049:GG:Gdonor_loss1.0000
15:63127050:G:GAdonor_loss1.0000
15:63127349:TTAG:Tacceptor_loss1.0000
15:63127350:TAG:Tacceptor_loss1.0000
15:63127352:G:Aacceptor_loss1.0000
15:63127686:CCTGG:Cdonor_loss1.0000
15:63127687:CTGG:Cdonor_loss1.0000
15:63127688:TGGTG:Tdonor_loss1.0000
15:63127689:GGTG:Gdonor_loss1.0000
15:63127690:GTGA:Gdonor_loss1.0000
15:63127691:T:Adonor_loss1.0000
15:63129468:C:Aacceptor_gain1.0000
15:63129471:A:AGacceptor_gain1.0000
15:63129471:AAT:Aacceptor_gain1.0000
15:63129472:A:Gacceptor_gain1.0000
15:63129473:T:TAacceptor_gain1.0000
15:63129646:GCAAG:Gdonor_gain1.0000
15:63129647:CAAG:Cdonor_loss1.0000
15:63129648:AAG:Adonor_loss1.0000

AlphaMissense

541 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
15:63155706:G:CF47L1.000
15:63155706:G:TF47L1.000
15:63155708:A:GF47L1.000
15:63154050:A:CF79L0.999
15:63154050:A:TF79L0.999
15:63154052:A:GF79L0.999
15:63155635:G:TA71D0.999
15:63155641:C:AG69V0.999
15:63155644:C:AG68V0.999
15:63155644:C:TG68E0.999
15:63155655:G:CC64W0.999
15:63155681:A:GC56R0.999
15:63155698:G:TA50D0.999
15:63155703:G:CS48R0.999
15:63155703:G:TS48R0.999
15:63155704:C:AS48I0.999
15:63155705:T:GS48R0.999
15:63155708:A:TF47I0.999
15:63155710:A:TV46D0.999
15:63156419:A:GC37R0.999
15:63156432:A:CF32L0.999
15:63156432:A:TF32L0.999
15:63156434:A:GF32L0.999
15:63154047:T:AR80S0.998
15:63154047:T:GR80S0.998
15:63154048:C:AR80I0.998
15:63154048:C:GR80T0.998
15:63155621:C:AG76W0.998
15:63155641:C:TG69E0.998
15:63155656:C:TC64Y0.998

dbSNP variants (sampled 300 via entrez): RS1000263127 (15:63153702 G>C), RS1000303088 (15:63159325 G>A), RS1000576820 (15:63157659 T>G), RS1000629049 (15:63157842 G>A), RS1000635827 (15:63158129 G>T), RS1001621754 (15:63152962 T>C), RS1001966998 (15:63152375 G>A,T), RS1002114555 (15:63157545 C>A,T), RS1002224814 (15:63151519 C>T), RS1002269833 (15:63150868 C>G), RS1002308538 (15:63157188 T>C), RS1002682070 (15:63151975 T>C), RS1002722380 (15:63156165 T>C), RS1003065590 (15:63155976 T>C), RS1003275222 (15:63150832 G>T)

Disease associations

OMIM: gene MIM:612055 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST006249_61Serum metabolite levels1.000000e-21
GCST010002_172Refractive error6.000000e-36

Drugs & pharmacology

Drug and pharmacology data

Is drug target: yes

ChEMBL targets (1): CHEMBL6067311 (SINGLE PROTEIN)

PharmGKB: 1 entry (VIP=true, CPIC=false)

ChEMBL bioactivities

4 potent at pChembl≥5 of 4 total, top 4 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).

pChemblTypeValueUnitMolecule
8.37Kd4.316nMCHEMBL5653589
8.37ED504.316nMCHEMBL5653589
5.19Kd6464nMCHEMBL3752910
5.19ED506464nMCHEMBL3752910

PubChem BioAssay actives

2 with measured affinity, of 4 total; 2 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.

CompoundAssayTypeValueUnit
4-methyl-3-[(2-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide2149302: Binding affinity to human RPS27L incubated for 45 mins by Kinobead based pull down assaykd0.0043uM
4-methyl-3-[(1-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide2149302: Binding affinity to human RPS27L incubated for 45 mins by Kinobead based pull down assaykd6.4644uM

CTD chemical–gene interactions

91 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects cotreatment, increases expression, affects expression6
bisphenol Aaffects expression, decreases expression, increases expression4
Air Pollutantsincreases abundance, increases expression, decreases expression, affects cotreatment4
Cisplatinaffects expression, increases expression4
sodium arsenitedecreases expression, increases expression3
Benzo(a)pyreneincreases expression3
Fluorouracilaffects reaction, decreases expression, increases expression3
Cadmium Chloridedecreases reaction, increases abundance, increases palmitoylation, affects expression, increases expression3
mercuric bromideaffects cotreatment, increases expression2
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, increases expression2
Cadmiumdecreases reaction, increases abundance, increases palmitoylation, increases expression2
Doxorubicinincreases expression, affects expression2
Phenylmercuric Acetateaffects cotreatment, increases expression2
Tunicamycinaffects expression, increases expression2
Cyclosporinedecreases expression, increases expression2
Particulate Matterdecreases expression, increases abundance2
aristolochic acid Idecreases expression1
bisphenol Fincreases expression1
dicrotophosdecreases expression1
chloroacetaldehydeaffects expression1
alpha-pineneincreases expression, increases abundance, affects cotreatment1
beta-lapachoneincreases expression1
arseniteaffects binding, increases reaction1
tris(1,3-dichloro-2-propyl)phosphatedecreases expression1
potassium bromateincreases expression1
2-bromopalmitatedecreases reaction, increases abundance, increases palmitoylation1
N-benzyloxycarbonylprolylprolinalincreases expression1
methacrylaldehydeaffects cotreatment, increases expression, increases abundance1
beta-methylcholineaffects expression1
azoxystrobinincreases expression1

ChEMBL screening assays

1 unique, capped per target: 1 binding

Representative assays (with source publication via chembl_document):

Assay IDTypeDescriptionSource paper
CHEMBL5652344BindingBinding affinity to human RPS27L incubated for 45 mins by Kinobead based pull down assayNVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family. — ChemMedChem

Cellosaurus cell lines

1 cell lines: 1 cancer cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_B2E5Abcam HeLa RPS27L KOCancer cell lineFemale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.